AbstractBackgroundPatients with Brugada syndrome and aborted sudden cardiac death or syncope have higher risks for ventricular arrhythmias (VAs) and should undergo implantable cardioverter-defibrillator (ICD) placement. Device-based management of asymptomatic patients is controversial. ICD therapy is associated with high rates of inappropriate shocks and device-related complications.ObjectivesThe objective of this study was to investigate clinical features, management, and long-term follow-up of ICD therapy in patients with Brugada syndrome.MethodsPatients presenting with spontaneous or drug-induced Brugada type 1 electrocardiographic findings, who underwent ICD implantation and continuous follow-up at a single institution, were eligible fo...
AIMS: Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) t...
Introduction. Brugada syndrome is an arrhythmogenic disease characterized by coved ST segment eleva...
AIMS: Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) t...
BACKGROUND: Young patients presenting with symptomatic Brugada syndrome have very high risks for ven...
Background—Brugada syndrome is an arrhythmogenic disease characterized by an increased risk of sudde...
AbstractBackgroundIn Thailand and Southeast Asia, Brugada syndrome (BS) is a common inheritable caus...
Background and objectiveImplantation of a cardioverter defibrillator (ICD) is a frequently recommend...
Background: Brugada syndrome is an arrhythmogenic disease characterized by an ECG pattern of ST-segm...
Brugada syndrome (BS) is an arrhythmogenic disease characterized by an ECG pattern of ST-segment ele...
Brugada syndrome (BS) is an arrhythmogenic disease characterized by an ECG pattern of ST-segment ele...
Background: The role of programmed ventricular stimulation in identifying patients with Brugada synd...
Background: The role of programmed ventricular stimulation in identifying patients with Brugada synd...
AIMS Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) t...
Aims: Data on predictors of time-To-first appropriate implantable cardioverter-defibrillator (ICD) t...
In patients who undergo aborted sudden cardiac death or syncope of unknown origin (symptomatic Bruga...
AIMS: Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) t...
Introduction. Brugada syndrome is an arrhythmogenic disease characterized by coved ST segment eleva...
AIMS: Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) t...
BACKGROUND: Young patients presenting with symptomatic Brugada syndrome have very high risks for ven...
Background—Brugada syndrome is an arrhythmogenic disease characterized by an increased risk of sudde...
AbstractBackgroundIn Thailand and Southeast Asia, Brugada syndrome (BS) is a common inheritable caus...
Background and objectiveImplantation of a cardioverter defibrillator (ICD) is a frequently recommend...
Background: Brugada syndrome is an arrhythmogenic disease characterized by an ECG pattern of ST-segm...
Brugada syndrome (BS) is an arrhythmogenic disease characterized by an ECG pattern of ST-segment ele...
Brugada syndrome (BS) is an arrhythmogenic disease characterized by an ECG pattern of ST-segment ele...
Background: The role of programmed ventricular stimulation in identifying patients with Brugada synd...
Background: The role of programmed ventricular stimulation in identifying patients with Brugada synd...
AIMS Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) t...
Aims: Data on predictors of time-To-first appropriate implantable cardioverter-defibrillator (ICD) t...
In patients who undergo aborted sudden cardiac death or syncope of unknown origin (symptomatic Bruga...
AIMS: Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) t...
Introduction. Brugada syndrome is an arrhythmogenic disease characterized by coved ST segment eleva...
AIMS: Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) t...